Loading...
Mouse Study of Combined DNA/Protein COVID-19 Vaccine to Boost High Levels of Antibody and Cell Mediated Immune Responses
He, Qian ; Liu, Shuying ; Liang, Zhenglun ; Lu, Shan ; Cun, Wei ; Mao, Qunyan
He, Qian
Liu, Shuying
Liang, Zhenglun
Lu, Shan
Cun, Wei
Mao, Qunyan
Citations
Altmetric:
Student Authors
Faculty Advisor
Academic Program
UMass Chan Affiliations
Document Type
Accepted Manuscript
Publication Date
2022-11-25
Subject Area
Collections
Embargo Expiration Date
Link to Full Text
Abstract
In our previous studies, we showed the high immunogenicity of heterologous DNA prime, protein boost HIV vaccines in humans. More recently a combination DNA/Protein COVID-19 vaccine developed by us showed high immunogenicity and sterilizing protection in a non-human primate model against SARS-CoV-2 challenge. In the current study, we aim to test whether this combination DNA/Protein vaccine can also be used as a booster to other types of COVID-19 vaccines.
Source
He Q, Liu S, Liang Z, Lu S, Cun W, Mao Q. Mouse Study of Combined DNA/Protein COVID-19 Vaccine to Boost High Levels of Antibody and Cell Mediated Immune Responses. Emerg Microbes Infect. 2022 Nov 25:1-13. doi: 10.1080/22221751.2022.2152388. Epub ahead of print. PMID: 36426608.
Year of Medical School at Time of Visit
Sponsors
Dates of Travel
DOI
10.1080/22221751.2022.2152388
Permanent Link to this Item
PubMed ID
36426608
Other Identifiers
Notes
Funding and Acknowledgements
Corresponding Author
Related Resources
Related Resources
Repository Citation
Rights
© 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group, on behalf of Shanghai Shangyixun Cultural Communication Co., Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.